|
This is to inquire respecting the article
"The Highly Effective Use of Topical Zinc Pyrithione in the Treatment of
Psoriasis: A Case report".
I understand that the "novel topical preparation of zinc pyrithione" used
in this case is in fact the product known as 'Skin-Cap'.
Apparently this product has been discovered (by the Pharmaceutical
Institute of the University of Utrecht) to contain the corticosteroid
triamcinolon, and has been withdrawn from sale in the netherlands.
If Skin-Cap does contain corticosteroid, then the study in DOJ is surely
invalid, as the effect of Zinc Pyrithione on its own remains untried, and
the improvement shown would likely be due to the steroid.
I am most interested in any comments on this.
David Boyce
|